middle.news
Arovella Therapeutics Halts Trading Ahead of Capital Raise Details
9:41am on Monday 10th of February, 2025 AEDT
•
Biotechnology
Read Story
Arovella Therapeutics Halts Trading Ahead of Capital Raise Details
9:41am on Monday 10th of February, 2025 AEDT
Key Points
Voluntary suspension effective from 10 February 2025
Suspension requested to manage continuous disclosure obligations
Material update related to capital raising placement announced in January
Suspension to last until announcement release or 17 February 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Arovella Therapeutics (ASX:ALA)
OPEN ARTICLE